This inventor holds 1 USPTO granted patent. Top assignee: Aviron. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Frances C. Spector: Innovating HSV-2 Treatment Solutions
Introduction
Frances C. Spector, an accomplished inventor based in Mountain View, CA, has made significant contributions in the field of virology and medical treatments. With a keen focus on the development of innovative therapeutic solutions, she holds one notable patent that addresses the treatment of HSV-2 infections.
Latest Patents
Frances C. Spector's patent is titled "Methods and compositions for treatment of HSV-2 infections and conditions." This groundbreaking work involves a live, attenuated HSV-2 virus created through recombinant techniques. The invention provides methods for making and using this virus in a pharmaceutical composition aimed at both the prophylactic treatment and the management of recurrent HSV-2 related diseases. Additionally, her patent includes a plasmid vector for expressing a GST-UL56 fusion protein. This fusion protein not only helps in producing polyclonal antisera for the HSV-2 UL56 gene product but also serves as a reagent to differentiate between HSV-1 and HSV-2.
Career Highlights
Frances C. Spector is affiliated with Aviron, where she has played a pivotal role in advancing medical research and innovation. Her keen insights into viral treatments have positioned her as a knowledgeable contributor in her field. With her unique background and expertise, she has focused her career on developing effective solutions for viral infections.
Collaborations
Throughout her career, Frances has collaborated with esteemed colleagues such as Bernard Roizman and Richard R. Spaete. These partnerships have greatly enhanced her research capabilities and have driven the innovative work that has culminated in her patent contributions.
Conclusion
Frances C. Spector represents the spirit of innovation in the medical field, particularly in the realm of antiviral therapies. Her work has the potential to significantly improve the lives of those affected by HSV-2 infections. Through her patent and collaborations, she continues to inspire future research and advancements in virology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile